EAPH - Easton Pharmaceuticals Inc.

Other OTC - Other OTC Delayed Price. Currency in USD

Easton Pharmaceuticals Inc.

Brockhouse Road
Toronto, ON
Canada
647-362-5700
http://www.eastonpharmaceuticalsinc.com

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Evan KarrasCEO, Pres, Sec. & DirectorN/AN/AN/A
Mr. Nunzio J. Valerie Jr.CFO & DirectorN/AN/A1962
Mr. Vince DemasiCOO & DirectorN/AN/AN/A
Dr. Lilla Albert Ph.D.Chief Marketing and Technology OfficerN/AN/AN/A
Ms. Elena MilantoniDirector of Fin. and Admin.N/AN/A1970
Amounts are as of and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, develops and markets various topically delivered drugs to treat cancer and other therapeutic products to treat various conditions. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; and Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is headquartered in Toronto, Canada.

Corporate Governance

Easton Pharmaceuticals Inc.’s ISS Governance QualityScore as of July 29, 2019 is 6. The pillar scores are Audit: 1; Board: 7; Shareholder Rights: 6; Compensation: 5.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.